Berry Genomics, Ajlan & Bros Form Reproductive Health Testing Joint Venture in Middle East
Berry Genomics subsidiary Xcelom and Ajlan & Bros will partner to provide noninvasive prenatal testing (NIPT) and other genetic testing in Saudi Arabia and the Middle East.
Berry Oncology Raises $99.2M in Series B1 Round
The company, a subsidiary of Beijing-based Berry Genomics, offers cancer screening tests including a next-generation sequencing-based assay for liver cancer.
Berry Oncology, Alibaba Health Partner to Offer Early Cancer Screening, Health Services
As part of the deal, the companies will offer Berry Oncology's Lai Si Ning next-generation sequencing-based liver cancer screening test.
Pacific Biosciences Targets China Clinical Market to Rebound After Illumina Deal Falls Through
PacBio will try to take the Sequel II to the clinic in China with the help of Berry Genomics and is open to partnerships globally, including with Illumina.
Bionano Customers Explore Diagnostic Applications of Genome Maps in Cancer, Genetic Disorders
Several groups are comparing Bionano with standard cytogenetic assays like karyotyping, FISH, or array CGH for blood cancer or genetic disease testing.